Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes

被引：1
|
作者：
Prutsky, Gabriela [1 ]
Domecq, Juan Pablo [1 ]
Tsapas, Apostolos [1 ]
机构：
[1] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2012年 / 156卷 / 02期
关键词：
D O I：
10.7326/0003-4819-156-2-201201170-02007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Initial Monotherapy with Sulfonylurea Is Associated with Increased Likelihood of Insulin Initiation Compared with Metformin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in the United Kingdom
    Zhao, Changgeng
    Zhang, Qiaoyi
    Engel, Samuel
    Mavros, Panagiotis
    DIABETES, 2010, 59 : A187 - A187
  • [32] Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes
    Johnson, JA
    Simpson, SH
    Toth, EL
    Majumdar, SR
    DIABETIC MEDICINE, 2005, 22 (04) : 497 - 502
  • [33] Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
    Landman, Gijs W. D.
    Kleefstra, Nanne
    van Hateren, Kornelis J. J.
    Groenier, Klaas H.
    Gans, Rijk O. B.
    Bilo, Henk J. G.
    DIABETES CARE, 2010, 33 (02) : 322 - 326
  • [34] The likelihood of initiating insulin is increased in UK patients with newly diagnosed type 2 diabetes who received initial monotherapy with sulphonylurea compared with metformin
    Mavros, P.
    Zhao, C.
    Zhang, Q.
    Engel, S. S.
    DIABETOLOGIA, 2010, 53
  • [35] Incretin mimetics and enhancers: New insulin secretagogues for Type-2 diabetes
    Mahajan, Rajiv
    Gupta, Kapil
    BIOMEDICAL RESEARCH-INDIA, 2010, 21 (01): : 99 - 105
  • [36] Efficacy and mechanism of insulin secretagogues and acarbose in newly diagnosed type 2 diabetes
    Fan, Shizhen
    Ma, Jianxin
    Ma, Meiling
    Niu, Ruifang
    Ma, Yuehua
    Zhao, Zhigang
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 : 4 - 5
  • [37] Continuation vs. Discontinuation of Insulin Secretagogues When Initiating Insulin in Type 2 Diabetes
    Swinnen, Sanne G.
    Dain, Marie-Paule
    Mauricio, Didac
    Devries, J. Hans
    Hoekstra, Joost B.
    Holleman, Frits
    DIABETES, 2010, 59 : A10 - A10
  • [38] Advantages of therapy with glargine insulin and metformin versus NPH insulin and metformin in patients with diabetes mellitus type2 associated obesity
    Moldovan, C.
    Vatc, L.
    Farca, D.
    Demian, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S128 - S128
  • [39] Metformin and insulin in type 1 Diabetes
    Meyer, L
    Guerci, B
    DIABETES CARE, 2003, 26 (05) : 1655 - 1656
  • [40] Preadmission Insulin Treatment Was Associated with Increased In-Hospital Mortality among Critically III Patients with Type 2 Diabetes
    Fan, Rongping
    DIABETES, 2021, 70
12345